Suma Krishnan
CIK 1298711 · President, R&D · last filed 2026-06-05
Suma Krishnan is a President, R&D who has filed 42 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $7.7M of KRYS on Jun 5, 2026. Across all open-market trades the lifetime net is −$125.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $454.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$454.84M
3
42
-$125.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRYS | President, R&D | 1,430,434 | $317.97 | $454.84M | -$124.60M | 37 | 2026-06-05 |
| PRECIGEN, INC. (XON) Delisted | SVP--Product Development | 113,314 | — | — | -$745.4K | 4 | 2016-02-01 |
| NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted | Vice President, Product Dev. | — | — | — | $0 | 1 | 2007-01-31 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | KRYS | Sell (S) | −25,000 | -$7.70M | EDGAR |
| 2026-03-06 | KRYS | Sell (S) | −25,000 | -$6.58M | EDGAR |
| 2026-03-03 | KRYS | Mixed | +36,641 | -$8.43M | EDGAR |
| 2025-12-05 | KRYS | Mixed | −55,000 | -$11.01M | EDGAR |
| 2025-07-16 | KRYS | Sell (S) | −35,873 | -$5.40M | EDGAR |
| 2025-07-11 | KRYS | Sell (S) | −14,127 | -$2.12M | EDGAR |
| 2025-03-13 | KRYS | Sell (S) | −50,000 | -$8.89M | EDGAR |
| 2025-02-28 | KRYS | Mixed | +33,623 | -$7.84M | EDGAR |
| 2024-12-13 | KRYS | Sell (S) | −50,000 | -$8.24M | EDGAR |
| 2024-09-13 | KRYS | Sell (S) | −50,000 | -$9.89M | EDGAR |